CRDF Message Board Post 10896068 | Cardiff Oncology Inc.
home / stock / crdf / crdf message board
(investorshangout)
Posted on: Apr/02/2019 12:05:40
Source: investorshangout
https://investorshangout.com/post/view?id=5400067
whytestocks: $TROV News Article - Early Data from Phase 2 Trial Indicates Activity of Onvansertib in Prostate Can
News, Short Squeeze, Breakout and More Instantly...
-
SAN DIEGO, May 13, 2024 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, today announced that company management will present at two upcoming investor conferences in M...
-
- In RAS-mutated mCRC, clinical data from ONSEMBLE trial, and preclinical data presented at AACR, demonstrated strong efficacy signal in bev naïve patients and support ongoing first-line RAS-mutated mCRC lead program - - In RAS wild-type mCRC, preclinical data presented at AACR dem...